Endogenous brain protection: models, gene expression, and mechanisms.
Barone
Frank C
FC
High-Throughput Biology, Discovery Research, GlaxoSmithKline Pharmaceuticals, King of Prussia, PA, USA.
D000818:Animals; D001483:Base Sequence; D001930:Brain Injuries / Q000209:etiology / Q000235:genetics* / Q000517:prevention & control* / Q000628:therapy; D002545:Brain Ischemia / Q000209:etiology / Q000235:genetics / Q000517:prevention & control / Q000628:therapy; D018076:DNA, Complementary / Q000235:genetics; D004195:Disease Models, Animal; D015870:Gene Expression; D006360:Heat-Shock Proteins / Q000235:genetics; D006801:Humans; D066298:In Vitro Techniques; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1 / Q000096:biosynthesis / Q000235:genetics; D019194:Ischemic Preconditioning; D008297:Male; D008959:Models, Neurological; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D011918:Rats, Inbred SHR; D012795:Sialoglycoproteins / Q000096:biosynthesis / Q000235:genetics; D015398:Signal Transduction
D018076:DNA, Complementary; D006360:Heat-Shock Proteins; C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D012333:RNA, Messenger; D012795:Sialoglycoproteins